During Episode 27 of Biotalk, Geoff Meyerson, CEO of Locust Walk, steps back to examine the macro forces shaping the biopharma landscape. After holding a bearish outlook since 2021, Geoff explains why

During the Asia-focused Episode 26 of Biotalk, Geoff Meyerson, CEO ofLocust Walk, shares fresh insights from Japan, China, and Korea, as featured in our2025 Q1 Report: Global Trends in Biopharma Tra

During Episode 25 of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2025 Q1 Report: Global Trends in Biopharma Transactions Report, covering capital markets, strategic deals, and regional tr

During this episode of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2024 Q3 Report: Global Trends in Biopharma Transactions Report.Each quarter, Locust Walks deal team compiles key stati

On this episode of Biotalk, Locust WalksAndy MeyersonwelcomesDr. Lindsay Rosenwald, Chairman, President and Chief Executive Officer ofFortress Biotech, a company focused on licensing and developi